The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $34.96

Today's change-0.04 -0.11%
Updated March 31 12:42 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $34.96

Today's change-0.04 -0.11%
Updated March 31 12:42 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc down (U.S.)$0.04

Pfizer Inc is lower today, dropping (U.S.)$0.04 or 0.11% to (U.S.)$34.96. Over the last five days, shares have gained 1.27% and are currently 1.38% off of the 52-week high. Shares have underperformed the S&P 500 by 2.15% during the last year.

Key company metrics

  • Open(U.S.) $34.89
  • Previous close(U.S.) $35.00
  • High(U.S.) $35.05
  • Low(U.S.) $34.76
  • Bid / Ask(U.S.) $34.95 / (U.S.) $34.96
  • YTD % change+12.23%
  • Volume7,477,724
  • Average volume (10-day)33,231,912
  • Average volume (1-month)29,916,738
  • Average volume (3-month)30,276,004
  • 52-week range(U.S.) $27.51 to (U.S.) $35.45
  • Beta0.79
  • Trailing P/E24.66×
  • P/E 1 year forward16.75×
  • Forward PEG7.73×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield3.20%
  • Trailing EPS(U.S.) $1.42
Updated March 31 12:42 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.39%

Based on its net profit margin of 18.39%, Pfizer Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.07%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014
Revenue13,11812,36112,77311,353
Total other revenue--------
Total revenue13,11812,36112,77311,353
Gross profit10,43310,00610,3279,314
Total cost of revenue2,6852,3552,4462,039
Total operating expense11,2158,6218,5998,440
Selling / general / administrative3,9813,5563,5203,040
Research & development3,2091,8021,7591,623
Depreciation / amortization9499721,0011,117
Interest expense (income), net operating--------
Unusual expense (income)53126595873
Other operating expenses, total-140-329-222-252
Operating income1,9033,7404,1742,913
Interest income (expense), net non-operating-353-343-343-321
Gain (loss) on sale of assets215333181
Other--------
Income before tax1,8033,5874,0032,847
Income after tax1,2582,6762,9212,265
Income tax, total5459111,082582
Net income1,2292,6672,9122,329
Total adjustments to net income-1-1-10
Net income before extra. items1,2512,6702,9122,256
Minority interest-7-6-9-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2502,6692,9112,256
Inc. avail. to common incl. extra. items1,2282,6662,9112,329
Diluted net income1,2282,6662,9122,329
Dilution adjustment----1--
Diluted weighted average shares6,3736,4036,4446,476
Diluted EPS excluding extraordinary itemsvalue per share0.200.420.450.35
Dividends per sharevalue per share0.260.260.260.26
Diluted normalized EPSvalue per share0.280.450.450.45